Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
暂无分享,去创建一个
R. Salgia | T. Owonikoko | S. Ramalingam | Shi-Yong Sun | Mingwei Chen | R. Kanteti | Guojing Zhang | P. Yue | Jacob J. Riehm | Y. Oh | Weilong Yao | Yikun Li | Puyu Shi